OpenAlex
PricingAboutJobs
Log inGet started
Work

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis

HTML

Year: 2014
Type: article
Source: Journal of Allergy and Clinical Immunology
DOI: 10.1016/j.jaci.2013.11.026
Authors: Pranabashis Haldar, Christopher E. Brightling, Amisha Singapuri, Beverley Hargadon, Sumit Gupta, William Monteiro, Peter Bradding, Ruth H. Green, Andrew J. Wardlaw, Hector Ortega, Ian D. Pavord
Institutions: University of Leicester, Glenfield Hospital, GlaxoSmithKline (United States), University of Oxford
Language: English

Topic: Asthma and respiratory diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: mepolizumab, eosinophilic asthma, severe asthma, treatment discontinuation, anti-IgE therapy, asthma outcomes, follow-up analysis
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute for Health and Care Research
Awards: G6979762771, NIHR Senior Investigator Award, NIHR Senior Investigator Award
OpenAlex ID: W2057490898
FWCI: 14.94
Cites: 8
Cited by: 197
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms